Deutsche Cannabis AG buy Traumtanz
Start price
21.01.23
/
50%
€0.58
Target price
31.05.24
-
Performance (%)
-
End price
25.01.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Deutsche Cannabis AG | - | - | - |
| iShares Core DAX® | 0.961% | -2.210% | 12.839% |
| iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% |
| iShares Nikkei 225® | 0.217% | -7.216% | 19.425% |
| iShares S&P 500 | 1.540% | -1.858% | 27.801% |
According to Traumtanz what are the pros and cons of Deutsche Cannabis AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
ROE higher than 10% per year
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Leading role in innovation
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Small cyclical dependencies
Known brand
Future proof or reliable business model
Good culture
Some uniques
Top 10 in its market
